Toxicology of suicide: Touchstone for suicide prevention?

Medical Science Monitor

Volumn 9, Issue 4, 2003, Pages

  Dhossche, Dirk M ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Monitoring; Prevention; Psychotropic medications; Suicide; Toxicology

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CARBAMAZEPINE; CARBAMIC ACID DERIVATIVE; CENTRAL STIMULANT AGENT; CHLORPROMAZINE; CLOMIPRAMINE; CLOZAPINE; CODEINE; DEXTROPROPOXYPHENE; DIHYDROCODEINE; DOXEPIN; ETHCHLORVYNOL; HALOPERIDOL; HYDROCODONE; HYPNOTIC SEDATIVE AGENT; IMIPRAMINE; LITHIUM; MAPROTILINE; NEUROLEPTIC AGENT; OPIATE; PARACETAMOL; PSYCHOTROPIC AGENT; UNINDEXED DRUG; ZOLPIDEM;

ARTICLE; CLINICAL TRIAL; DEPRESSION; DRUG OVERDOSE; ETHICS; HUMAN; PREVENTIVE MEDICINE; PSYCHOTHERAPY; RISK FACTOR; SUBSTANCE ABUSE; SUICIDE; SUICIDE ATTEMPT; TOXICOLOGY;

AGE FACTORS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; PSYCHOTROPIC DRUGS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SUBSTANCE-RELATED DISORDERS; SUICIDE; TOXICOLOGY;

EID: 0038221030     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Joiner T Jr: The trajectory of suicidal behavior over time. Suicide Life Threat Behav, 2002; 32: 33-41
2. Robins E, Murphy GE, Wilkinson RH et al: Some clinical considerations in the prevention of suicide based on a study of 134 successful suicides. Am J Public Health, 1959; 49: 888-899
3. Dorpat TL, Ripley HS: A study of suicide in the Seattle area. Compr Psychiatry, 1960; 1: 349-359
4. Barradough B, Bunch J, Nelson B, Sainsbury P: A hundred cases of suicide: Clinical aspects. Br J Psychiatry, 1974; 125: 355-373
5. Chynoweth R, Tonge JI, Armstrong J: Suicide in Brisbane: A retrospective psychosocial study. Aust N Z J Psychiatry, 1980; 14: 37-45
6. Rich CL, Young D, Fowler RC: San Diego suicide study: I. Young vs old subjects. Arch Gen Psychiatry, 1986; 43: 577-582
7. Arató M, Demeter E, Rihmer Z, Somogyi E: Retrospective psychiatric assessment of 200 suicides in Budapest. Acta Psychiatr Scand, 1988; 77: 454-456
8. Runeson B: Mental disorder in youth suicide. Acta Psychiatr Scand, 1989; 79: 490-497
9. Beskow J: Suicide and mental disorder in Swedish men 1970-71. Acta Psychiatr Scand, 1979; (suppl 277)
10. Åksgærd U: A psychiatric study of suicide among urban Swedish women. Acta Psychiatr Scand, 1990; 82: 115-124
11. Cheng ATA: Mental illness and suicide: A case-control study in east Taiwan. Arch Gen Psychiatry, 1995; 52: 594-603
12. Shaffer D, Gould MS, Fisher P et al: Psychiatric diagnosis in child and adolescent suicide. Arch Gen Psychiatry, 1996; 53: 339-348
13. Harris E, Barraclough BM: Suicide as an outcome for mental disorders. Br J Psychiatry, 1997; 170: 205-228
14. Brent D, Perper J, Moritz G et al: Suicide in adolescents with no apparent psychopathology. J Am Acad Child Adolesc Psychiatry, 1993; 32: 494-500
15. Owens D, Horrocks J. House A: Fatal and non-fatal repetition of self-harm. A systematic review. Br J Psychiatry, 2002; 181: 193-199
16. Cullberg J, Wasserman D, Stefansson CG: Who commits suicide after a suicide attempt. Acta Psychiatr Scand, 1988; 77: 598-603
17. Carney SS, Rich CL, Burke PA, Fowler RC: Suicide over 60: The San Diego study. J Am Geriatr Soc, 1994; 42: 174-180
18. Isometsä E, Lönnquist J: Suicide attempts preceding completed suicide. Br J Psychiatry, 1998; 173: 531-535
19. Beautrais A, Joyce P, Mulder R et al: Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: A case-control study. Am J Psychiatry, 1996; 153: 1009-1014
20. Persson ML, Runeson B, Wasserman D: Diagnoses, psychosocial stressors and adaptive functioning in attempted suicide. Ann Clin Psychiatry, 1999; 11: 119-128
21. Dhossche D, Meloukheia AM, Chakravorty S: The association of suicide attempts and comorbid mood and substance abuse disorders in psychiatric consultation patients. Gen Hosp Psychiatry. 2000; 22: 281-288
22. Elliott AJ, Pages KP, Russo J et al: A profile of medically serious suicide attempts. J Clin Psychiatry, 1996; 57: 567-571
23. Henriksson MM, Aro HM, Marttunen MJ et al: Mental disorders and comorbidity in suicide. Am J Psychiatry, 1993; 150: 935-940
24. Isacsson G, Rich CL: Depression, antidepressants, and suicide: Pharmacoepidemiological evidence for suicide prevention. In: Maris R, Canetto S. Silverman M, eds. Review of Suicidology, 1997. New York: Guilford Publications, Inc, 1997; 168-201
25. Rich CL, Fowler RC, Young D: Substance abuse and suicide. The San Diego study. Ann Clin Psychiatry,. 1989; 1: 79-85
26. Blair-West G, Mellsop G, Eyeson-Annan M: Down-rating lifetime suicide risk in major depression. Acta Psychiatr Scand, 1997; 95: 259-263
27. Inskip H, Harris E, Barraclough BM: Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. Br J Psychiatry, 1998; 172: 35-37
28. Murphy GE, Wetzel RD: The lifetime risk of suicide in alcoholism. Arch Gen Psychiatry, 1990; 47: 383-392
29. Murphy G: The prediction of suicide: why is so difficult? Am J Psychotherapy, 1984; 38: 341-349
30. Pokorny A: Prediction of suicide in psychiatric patients. Report of a retrospective study. Arch Gen Psychiatry, 1983; 40: 249-257
31. Goldstein R, Black D, Nasrallah A, Winokur G: The prediction of suicide. Sensitivity, specificity, and predictive value of a multivariate model applied to suicide among 1906 patients with affective disorders. Arch Gen Psychiatry, 1991; 48: 418-422
32. Dhossche D, Ulusarac A, Syed W: A retrospective study of general hospital patients who commit suicide shortly after being discharged from the hospital. Arch Intern Med, 2001; 161: 991-994
33. Beskow J, Kerkhof A, Kokkola A, Uutela A: Suicide prevention in Finland 1986-1996: external evaluation by an international peer group. Helsinki: Ministery of Social Affairs and Health, 1999
34. Breton JJ, Boyer R, Bilodeau H et al: Is evaluative research on youth suicide programs theory-driven? The Canadian experience. Suicide Life Threat Behav, 2002; 32: 176-190
35. Murphy G. Suicide and substance abuse. Arch Gen Psychiatry, 1988; 45: 593-594
36. Khan A, Warner H, Brown W: Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials. Arch Gen Psychiatry, 2000; 57: 311-317
37. Storosum J, van Zwieten B, van den Brink W et al: Suicide risk in placebo-controlled studies of Major. Depression. Am J Psychiatry, 2001; 158: 1271-1275
38. Kraemer HC: Statistical analysis to settle ethical issues? (letter). Arch Gen Psychiatry, 2000; 57: 327-328
39. Michels K: The placebo problem remains (letter). Arch Gen Psychiatry, 2000; 57: 321-322
40. Tollefsen GD, Fawcett J, Winocur G et al: Evaluation of suicidality during pharmacologic treatment of mood and nonmood disorders. Ann Clin Psychiatry. 1993; 5: 209-224
41. Verkes R, Van der Mast R, Hengeveld MW et al: Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not Major Depression. Am J Psychiatry, 1998; 155: 543-547
42. Addington D, Williams R, Lapierre Y, el-Guebaly N: Placebos in clinical trials of psychotropic medication. Can J Psychiatry, 1997; 42: 6
43. Institute of Medicine of the National Academies: Reducing suicide. A national imperative. Washington, DC: The National Academies Press, 2002
44. Isacsson G, Holmgren P, Druid H, Bergman U: The utilization of antidepressants - a key issue in the prevention of suicide: An analysis of 5, 281 suicides in Sweden 1992-94. Acta Psychiatr Scand, 1997; 96: 94-100
45. Isacsson G: Suicide prevention - a medical breakthrough? Acta Psychiatr Scand, 2000; 102: 113-117
46. Rihmer Z, Kalmar S: Antidepressants and suicide prevention in Hungary (letter). Acta Psychiatr Scand, 2001; 103: 238-239
47. Safer D, Krager J: The increased rate of stimulant treatment for hyperactive/inattentive students in secondary schools. Pediatrics, 1994; 94: 462-464
48. Zito J M, Safer D, Dos Reis S et al: Rising prevalence of antidepressants among US youths. Pediatrics, 2002; 109: 721-727
49. Olfson M, Marcus S, Druss B et al: National trends in the outpatient treatment of depression. JAMA, 2002; 9: 203-209
50. Müller-Oerlinghausen B, Ahrens B, Grof P et al: The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness. Acta Psychiatr Scand, 1992; 86: 218-222
51. Tondo L, Jamison K, Baldessarini RJ: Effect of lithium maintenance on suicidal behavior in major mood disorders. Ann NY Acad Sci, 1997; 836: 339-351
52. Mendels J: Lithium in the treatment of depression. Am J Psychiatry, 1976; 133: 373-378
53. Modesfin J, Schwarzenbach F: Effect of psychopharmacotherapy on suicide risk in discharged psychiatric inpatients. Acta Psychiatr Scand, 1992; 85: 173-175
54. Coryell W, Arndt S, Turvey C et al: Lithium and suicidal behavior in major affective disorder: a case-control study. Acta Psychiatr Scand, 2001; 104: 193-197
55. Ahrens B, Müller-Oerlinghausen B, Schou M et al: Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. J Affect Dis, 1995; 33: 67-75
56. Rosen DH: The serious suicide attempt. JAMA, 1976; 235(19): 2105-2109
57. Schou M: Forty years of lithium treatment. Arch Gen Psychiatry, 1997; 54: 9-13
58. Tondo L, Hennen J, Baldessarini RJ: Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis. Acta Psychiatr Scand, 2001; 104: 163-172
59. Meltzer HY, Okayli G: Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: Impact on risk-benefit assessment. Am J Psychiatry, 1995; 152: 183-190
60. Reid W, Mason M, Hogan T: Suicide prevention effects associated with clozapine therapy in schizophrenia and schizoaffective disorder. Psychiatric Serv, 1998; 49: 1029-1033
61. Angst F, Stassen H, Clayton P, Angst J: Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Dis, 2002; 68: 167-181
62. Norton LE, Garriott JC, DiMaio VJM: Drug detection at autopsy: a prospective study of 247 cases. J Forensic Sci, 1982; 27: 66-71
63. McGuire FL, Birch H, Gottschalk LA et al: A comparison of suicide and non-suicide deaths involving psychotropic drugs in four major U. S. cities. Am J Public Health, 1976; 66: 1058-1061
64. Goodman RA, Istre GR, Jordan FB et al: Alcohol and Fatal Injuries in Oklahoma. J Stud Alcohol, 1991; 52(2): 156-161
65. Kubo SI, Dankwarth G, Puschel K: Blood alcohol concentrations of sudden unexpected deaths and non natural deaths. Forensic Sci Int, 1991; 52: 77-84
66. Öhberg A, Vuori E, Ojanperä I, Lönnqvist J: Alcohol and drugs in suicides. Br J Psychiatry, 1996; 169: 75-80
67. Marzuk PM, Tardiff K, Leon AC et al: Prevalence of cocaine use among residents of New York City who committed suicide during a one-year period. Am J Psychiatry, 1992; 149: 271-375
68. Garlow S: Age, gender, and ethnicity differences in patterns of cocaine and ethanol use preceding suicide. Am J Psychiatry, 2002; 159: 615-619
69. Pounder D, Jones G: Post-mortem drug redistribution - a toxicological nightmare. Forensic Sci Int. 1990; 45: 253-263
70. Kerswill R, Vicente M: Clozapine and postmortem redistribution (letter). Am J Psychiatry, 2003; 160: 184
71. Dhossche D, Rich C, Ghani S, Isacsson G: Patterns of psychoactive substance detection from routine toxicology in suicide in Mobile, Alabama, between 1990-1998. J Affect Dis, 2001; 64: 167-174
72. Dhossche D, Rich C. Isacsson G: Psychoactive substances in suicides: comparison of toxicological findings in two samples. Am J Forensic Med Pathol, 2001; 22: 239-243
73. Isacsson G, Holmgren P, Druid H, Bergman U: Psychotropics and suicide prevention. Implications from toxicological screening of 5281 suicides in Sweden 1992-1994. Br J Psychiatry, 1999; 174: 259-265
74. Isacsson G, Holmgren P, Wasserman D, Bergman U: Use of antidepressants among people committing suicide in Sweden. BMJ, 1994; 308: 506-509